# Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer

> **NCT00154700** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 40 (—)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Paclitaxel,Cisplatin,5-Fu,Folic Acid

## Key facts

- **NCT ID:** NCT00154700
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154700, "Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00154700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*